December 2, 2024 - 18:47

Zscaler, Inc. has announced impressive financial results for the first quarter of fiscal 2025, showcasing significant growth across multiple key metrics. The company's revenue has surged by 26% year-over-year, reaching a total of $628.0 million. This robust growth reflects the increasing demand for Zscaler's cloud-based security solutions in an ever-evolving digital landscape.
In addition to revenue growth, calculated billings also saw a notable increase, rising 13% year-over-year to $516.7 million. This indicates strong customer engagement and a solid pipeline for future revenue. Deferred revenue, a critical indicator of future earnings, grew by 27% year-over-year, totaling $1,783.7 million, further demonstrating the company's ongoing success.
While Zscaler reported a GAAP net loss of $12.1 million, this is a marked improvement compared to a loss of $33.5 million in the same period last year. On a non-GAAP basis, the company achieved a net income of $124.3 million, up from $86.4 million year-over-year, underscoring its operational efficiency and financial health.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...